Page 4 - SLIDES
P. 4

676P: CABOPRE: A phase II study of CABOZANTINIB prior to



                              cytoreductive nephrectomy (CN) in metastatic




                                                        renal cell carcinoma (mRCC)
   1   2   3   4   5   6   7   8   9